Ofer Guttman

952 total citations
12 papers, 656 citations indexed

About

Ofer Guttman is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ofer Guttman has authored 12 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Ofer Guttman's work include Phagocytosis and Immune Regulation (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Immune Cell Function and Interaction (3 papers). Ofer Guttman is often cited by papers focused on Phagocytosis and Immune Regulation (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Immune Cell Function and Interaction (3 papers). Ofer Guttman collaborates with scholars based in Israel, United States and Netherlands. Ofer Guttman's co-authors include Peleg Rider, Yaron Carmi, Charles A. Dinarello, Idan Cohen, Ron N. Apte, Elena Voronov, Malka R. White, Alex Braiman, Eli C. Lewis and Scot A. Marsters and has published in prestigious journals such as The Journal of Cell Biology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ofer Guttman

12 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Guttman Israel 8 295 236 103 89 71 12 656
Michal Cohen-Sfady Israel 6 330 1.1× 234 1.0× 67 0.7× 98 1.1× 53 0.7× 6 710
Eva Kaiser Germany 11 316 1.1× 311 1.3× 60 0.6× 81 0.9× 53 0.7× 16 713
Robert A. Barrington United States 18 577 2.0× 252 1.1× 85 0.8× 62 0.7× 44 0.6× 49 1.1k
Miroslava Krzyžanková Czechia 6 307 1.0× 253 1.1× 68 0.7× 66 0.7× 96 1.4× 9 775
Misato Hirai Japan 10 254 0.9× 291 1.2× 66 0.6× 100 1.1× 73 1.0× 22 847
Davis Sim United States 6 189 0.6× 199 0.8× 84 0.8× 59 0.7× 52 0.7× 7 838
Krisztina Futosi Hungary 10 655 2.2× 334 1.4× 88 0.9× 39 0.4× 60 0.8× 20 1.1k
Yury Chaly United States 10 203 0.7× 272 1.2× 65 0.6× 62 0.7× 86 1.2× 16 606
Yunjie Huang United States 10 282 1.0× 231 1.0× 103 1.0× 51 0.6× 26 0.4× 18 738
Jinhee Lee South Korea 14 252 0.9× 296 1.3× 87 0.8× 106 1.2× 83 1.2× 29 843

Countries citing papers authored by Ofer Guttman

Since Specialization
Citations

This map shows the geographic impact of Ofer Guttman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Guttman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Guttman more than expected).

Fields of papers citing papers by Ofer Guttman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Guttman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Guttman. The network helps show where Ofer Guttman may publish in the future.

Co-authorship network of co-authors of Ofer Guttman

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Guttman. A scholar is included among the top collaborators of Ofer Guttman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Guttman. Ofer Guttman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guttman, Ofer, Adrien Le Thomas, Scot A. Marsters, et al.. (2022). Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation. The Journal of Cell Biology. 221(6). 28 indexed citations
2.
Harnoss, Jonathan M., Ofer Guttman, Scot A. Marsters, et al.. (2019). Caspase-mediated cleavage of IRE1 controls apoptotic cell commitment during endoplasmic reticulum stress. eLife. 8. 42 indexed citations
3.
Lior, Yotam, David E. Ochayon, Ronen Schuster, et al.. (2018). Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties. Frontiers in Immunology. 9. 759–759. 7 indexed citations
6.
Guttman, Ofer, et al.. (2016). Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin. Frontiers in Immunology. 7. 559–559. 15 indexed citations
8.
Rider, Peleg, Yaron Carmi, Rami Yossef, et al.. (2015). IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. The Journal of Immunology. 195(4). 1705–1712. 10 indexed citations
9.
Yossef, Rami, Chamutal Gur, Avishai Shemesh, et al.. (2015). Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLoS ONE. 10(2). e0118936–e0118936. 21 indexed citations
10.
Guttman, Ofer, et al.. (2014). Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats. Clinical & Experimental Immunology. 179(2). 161–172. 76 indexed citations
12.
Rider, Peleg, Yaron Carmi, Ofer Guttman, et al.. (2011). IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation. The Journal of Immunology. 187(9). 4835–4843. 421 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026